Collexis Creates a ‘MySpace’ for Scientists

Jan. 28, 2008 | You’re a life science researcher looking for experts in your scientific niche. Beyond your immediate circle of colleagues, how can you quickly find and connect with others who share your expertise?

A new online social network – BioMedExperts.com – could vastly simplify your search and help you connect with others in your field.

Launched this month by Collexis, a developer of high-definition search and knowledge discovery software, BioMedExperts.com is pre-populated with profiles of 1.5 million life science researchers and their published work, and is updated continually so researchers themselves need do nothing to keep their

  collexis-sm
  Click for larger
image
.
profiles current. It uses publicly available information from MedLine (the digital version of PubMed) and other sources to build its database, and is available at no cost to biomedical professionals.

Collexis, with U.S. headquarters in Columbia, S.C., specializes in concept-based expert profiling. Among its clients are Johns Hopkins and Harvard, and last week Collexis announced it will build an “advanced expert profiling system” for the 8000+ researchers at the National Institutes of Health.

Stephen Leicht, chief operating officer of Collexis, compares BioMedExperts to the social networks MySpace and LinkedIn in its functionality and ability to connect people. But BioMedExperts goes a step further in that it automatically keeps profiles updated. “There is no pre-populated social network like this anywhere, and we’ve done an exhaustive review,” Leicht says.

By taking the profile of documents and adding together all the documents written by the same person, BioMedExperts creates a profile of that person. Leicht says this profile “is often much more robust than even a resume or bio might be.”

The technology underlying BioMedExperts and other Collexis profiling systems is based on digital profiles of key ideas– so-called fingerprints – culled from various publicly available sources. Anything published in mainstream biomedical publications over the last 10 years has been picked up and indexed, according to Leicht.

“We take pieces of text  -- from websites, publications, transcripts, documents from document management repositories -- and we apply controlled vocabularies -- thesauri, ontologies, taxonomies, etc. – to them,” says Leicht. “So we have in our databases a profile for each document the system has ingested, and it automatically assigns concepts relevant to particular documents, as well as a weight for each concept.”

To the user, this weight, or relevance, is represented in a visual interface by a colored bar. The longer the bar, the more relevant the document and its authors to the searcher’s objective.

The landing page can be reconfigured but essentially it shows what’s going on in the user's field of research, the latest relevant articles or grants, what one's immediate coauthors are engaged in – and also shows random experts in the user's network and what they’re working on. It further filters the information in numerous ways:  by topic and sub-topic, co-authors, number of publications, affiliation, geographic location, and more. 

Once the user has found the profile of the researcher he'd like to contact, he can contact them through the network and invite them to join his community.

BioMedExperts also shows first-, second-, and third-level coauthors a user may “share” with the person he’s trying to connect with. If he's connected to them through a common coauthor, he can reach out to them through that individual.

For example, the user may be connected three levels away to Researcher Z – in other words has written at least one paper with researcher X; X has written one paper with Y; and Y has written one paper with Z. For any person in the database, he can click “more” and see all potential connections.



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .